INTRODUCTION
In spite of their well established clinical usefulness in the treatment of psychiatric, seizure and muscle spasm disorders, the sites and mechanisms of action of the benzodiazepines are as yet unknown. The recent discovery of specific benzodiazepine receptors on neuronal and glial cells (Braestrup and Squires, 1978; Hennand Henke, 1978) indicates that both types of cell may be involved. The evidence presented in this paper suggests that benzodiazepines may exert some of their actions by preventing adenosine uptake into neuronal and glial cells. The logical conclusion from our findings is that some benzodiazepine binding receptors may be associated with adenosine transport sites.
Although existing evidence points to an interaction between the benzodiazepine receptors and those for 7-aminobutyric acid (GABA) (Tallman et al., 1980), the localization of the benzodiazepine binding sites does not always coincide with those of the GABA receptors (Braestrup and Squires, 1978 ) and a search for additional mechanisms of action of the benzodiazepines appeared to be justified. In this context, the proposal (Klepner et al., 1979) that there are at least two biochemically distinct benzodiazepine receptor types in rat brain is of considerable interest. According to this scheme type I receptors, which are not coupled to GABA receptors, mediate the anxiolytic actions of the benzodiazepines. Type II receptors are coupled to GABA receptors and mediate other pharmacological effects such as sedation and ataxia.
It has been proposed that benzodiazepines may act by potentiating the effects of adenosine, a putative intercellular mediator in the brain (Phillis, 1979) had been terminated ( Fig. 2A) . Flurazepam evoked depression of neuronal firing was antagonized by theophylline (Fig. 2B, C) . Partial recovery of the flurazepam response occurred 1 hour after the second application of theophylline (Fig. 2D) . Evidence for a potentiative interaction between GABA and adenosine was sought in experiments on 17 rat cerebral cortical neurons. All of these cells were firing spontaneously and this firing was depressed by both compounds. There was however no indication of any synergistic interactions between GABA and adenosine. The results from one neuron are presented in Fig. 3 . GABA, applied by 30nA pulses, depressed spontaneous firing. 5'-AMP was then applied for several minutes with a current of 2nA. This was sufficient to slowly depress the rate of spontaneous firing but even so there was no indication that the effects of GABA were enhanced. These observations suggest that in the cerebral cortex, which is known to contain very high concentrations of the benzodiazepine receptor, there are unlikely to be potentiative interactions between GABA and adenosine. This finding is of some interest in the light of a recent report that in cerebral cortex, unlike cerebellar cortex, chlordiazepoxide and diazepam do not enhance GABA-evoked depressions (Assumpcao et al., 1979) .
ADENOSINE AND ACETYLCHOLINE RELEASE STUDIES To obtain in vivo evidence for an
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action of diazepam at the adenosine transport site, the effect of clinically used doses of this benzodiazepine on adenosine release from the rat cerebral cortex were determined (Phillis et al., 1980b) . Furthermore, since adenosine is known to affect acetylcholine (ACh) release from the cerebral cortex, the studies were extended to include ACh release. Diazepam (0.2S mg/kg) was observed to enhance the rate of efflux of ( 3 H)-adenosine and its derivatives from the cerebral cortex and at the same time to depress ACh release. Since theophylline antagonized the effect on ACh release, there is a strong possibility that this was secondary to the increases in extracellular adenosine levels. Pentobarbital sodium and ethanol were without effect on adenosine release from the cortex and it is therefore unlikely that the diazepam effects were a result of alterations in the level of anesthesia. 
ADENOSINE UPTAKE
CONCLUSIONS
The findings of our investigations into the effects of benzodiazepines on adenosine's actions on cerebral cortical neurons; its release from the cerebral cortex; and its uptake into rat cortical synaptosomes are all consistent with the hypothesis that the benzodiazepines elicit at least some of their effects by reducing adenosine uptake from the extracellular space. Adenosine actions seem to be important in those pathways which control the level of anxiety for caffeine, a potent adenosine antagonist, has a well known anxiety-provoking action and the benzodiazepines are widely used to control anxiety. The adenosine uptake site may therefore correspond to the type I benzodiazepine receptor postulated by Klepneret al. (1979) . A new finding which adds significant support to this proposal is the recent discovery that the adenosine uptake antagonist, dipyridamole, is a potent displacer of ( 3 H) diazepam binding in rat brain (Davies et al., 1980) . Studies with other adenosine uptake inhibitors should further strengthen our hypothesis.
